UK Study Advances Gene Therapy Development for Alzheimer's Disease

University of Bristol researchers have made significant progress in developing gene therapies for Alzheimer's disease, offering new hope for preventing or delaying the condition. Kevin Kemp, associate professor at the University of Bristol's School of Psychology and Neuroscience and lead researcher on the project, stated that while the study is still in its early stages, the team aims to target the APOE4 gene—a key risk factor—to ultimately develop new treatments for Alzheimer's disease.